A NEW IDEA ON BIOTECH MARAVAI — SUPPLIES A KEY COMPONENT OF CORONAVIRUS VACCINE
Maravai LifeSciences (MRVI) supplies a key component of the coronavirus vaccine produced by Pfizer (PFE) and BioNTech (BNTX). The vaccine should provide a sharp increase in revenue. The company also has a diversified product portfolio.
Zones
For those following the Good Way, the Buy Now rating is ‘YES.’
For those following the Best Way the buy zone is $23 to $26.76. MRVI is trading at $26.31 as of this writing in the premarket.
The stop zone is $21.38 to $22.33. The first target zone is $29 to $32. The second target zone is $35 to $38. The maximum quantity is 30% of full core position size.… Please click here or the title below to read more.
December 15, 2020